# A Short Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder

> **NCT01617447** · PHASE3 · COMPLETED · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 92 (actual)

## Conditions studied

- Autistic Disorder

## Interventions

- **DRUG:** Placebo of Aripiprazole
- **DRUG:** Aripiprazole

## Key facts

- **NCT ID:** NCT01617447
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2017-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01617447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01617447, "A Short Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01617447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*